Mednovo Group Co., Ltd.

About Us

—————

Strives for becoming the world’s leading

high-tech medical solution provider

in the field of mini-invasive intervention.

9-12 -鸿运国际厂房图 2.png

Mednovo Group

2 灰色细线.jpg

Mednovo Group, a diversified large group covers R&D, production, sales, investment and financing, focusing on the medical and health industry.

In Nov. 2020, the headquarter of Mednovo Group was officially settled in the high-tech zone of Suzhou. By establishing various innovative medical device projects in the “self-research + acquisition + equity” model, the company has laid out diversified racing tracks, and achieved the initial construction of a R & D, production and operation system of internationally advanced level, thereby forming a great picture of the industrial technology strategy of the group.

Basing on sales, with strategies as the pulling power, relying on the financial strength,science and technology innovation as the breakthrough point, the future Mednovo Group will carry out R & D of innovative products with independent intellectual property rights, high technology and high quality. Taking root in China and facing the world, the company relies on continuous R & D investment and advanced products to expand market, and strives for becoming the world’s leading high-tech medical solution provider in the field of mini-invasive intervention.

History

红色细线.jpg

2020

In Jan, Mednovo invested in and became the holding company of Beijing Sanhe Dingye Technology Co., Ltd and Wuxi Heyun Medical Technology Co., Ltd. In Aug, Oocyte collector got NMPA approval for classⅡmedical device. In Aug, Disposable embryo transfer catheter got NMPA approval for classⅡmedical device. In Nov, Mednovo signed a strategic cooperation agreement with Suzhou High-tech Zone Management Committee In Dec, Guidewire control handle got NMPA approval for classⅠmedical device In Dec, Invested in and became the holding company of Hangzhou Korigin Medical Device Co., Ltd and Hangzhou Revita Medical Technology Co., Ltd In Dec, Mednovo Group Co., Ltd .was officially founded. In Dec, Artificial insemination catheter got NMPA approval for classⅡmedical device

2021

In Jan, Disposable guide wire successfully launched. In Jan, Disposable catheter sheath group got NMPA approval for Class III medical device In Feb, Suzhou Mednovo-Cheng Medical Technology Co., Ltd. established, along with Mednovo-Xin, Mednovo-Zhi, Mednovo-Yuan. In Jun, Disposable sterile oocyte collection needle got NMPA approval for Class II medical device. In Jun, Suzhou Mednovo-Rui Medical Technology Co., Ltd. established, along with Mednovo-Yi, Mednovo-Chuang, Mednovo-Xin. In Sept, All patients enrollment completed for the clinical trial of microwave ablation for lower limb varicose veins. In Nov, Disposable peripheral vascular guide catheter got NMPA approval for Class III medical device.

2022

In Feb, Jingtu Medical Instrument (Jiangsu) Co., LTD established. In Sept, Mednovo Medical Device Industrial Park started construction. In Oct, TCZX Supply Chain Management (Jiangsu) Co., LTD established. In Oct, All patients enrollment completed for the clinical trial of Rapamycin Balloon Dilatation Catheter. In Nov, Received official accreditation as Suzhou headquarters enterprise In Dec, Disposable microcatheter got NMPA approval for Class III medical device.

2023

In Jan, Mednovo won the award for 2022 Key Project of Suzhou Taihu Science town Functional Area. In Feb, Drug Coated PTCA Balloon Dilatation Catheter got NMPA approval for Class III medical device. In Mar, Mednovo won the award for key project of Jiangsu Province's service industry In Apr, Mednovo won the award for 2023 innovative small and medium-sized Enterprise in Jiangsu Province. In May, Mednovo’s 12th anniversary celebration successfully held in Yan 'an. In Jun, First commercial implantation of Drug coated PTCA Balloon Dilation Catheter in The Third People Hospital of Chengdu after its recent NMPA approval. In Jun, Disposable sterile catheter sheath got NMPA approval for Class II medical device. In Jul, Disposable microcatheter successfully launched. In Sept, Embryo transfer catheter assist device got NMPA approval for Class II medical device.

2020

2021

2022

2023